Actively Recruiting
Cerebellar tDCS in Children With Autism Spectrum Disorder
Led by University of Texas Southwestern Medical Center · Updated on 2025-05-01
60
Participants Needed
2
Research Sites
356 weeks
Total Duration
On this page
Sponsors
U
University of Texas Southwestern Medical Center
Lead Sponsor
U
United States Department of Defense
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this research study is to investigate whether tDCS to the cerebellum (specifically, the right crus I/II area of the cerebellum) of children and young adults with autism spectrum disorders (ASD) is safe and to examine its effects on some of the symptoms of ASD, such as repetitive behaviors and hyperactivity.
CONDITIONS
Official Title
Cerebellar tDCS in Children With Autism Spectrum Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 4 and 17 years
- Diagnosed with autism spectrum disorder using ADOS-2
- IQ score of at least 70 (no less than 1.5 standard deviations below the mean)
- Language skills include flexible, spontaneous, simple sentences
You will not qualify if you...
- Presence of brain implants, metal implants, pacemakers, or other biomedical devices
- Diagnosis of epilepsy
- Hearing or visual impairments
- History of brain injury
- Known brain abnormalities not related to autism spectrum disorder
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Children's Medical Center
Dallas, Texas, United States, 75235
Actively Recruiting
2
University of Texas Southwestern
Dallas, Texas, United States, 75390
Actively Recruiting
Research Team
P
Peter Tsai, MD, PhD
CONTACT
A
Amy Magallanes
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here